Mengfei Chen

Mengfei Chen


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Cell Stem Cell
Verified
Journal Article
Closed access
MCMengfei Chen
Mengfei Chen
RRRandall R. Reed
Randall R. Reed
ALAndrew P. Lane
Andrew P. Lane

18 August 2020 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
MCMengfei Chen
Mengfei Chen
WSWenjuan Shen
Wenjuan Shen
NRNicholas R. Rowan
Nicholas R. Rowan
HKHeather Kulaga
Heather Kulaga
AHAlexander Hillel
Alexander Hillel
ALAndrew P. Lane
Andrew P. Lane
ACE2 protein is expressed at high levels in the human olfactory epithelium relative to upper airway epithelial cells. This may explain COVID-19-associated olfactory dysfunction, while suggesting a SARS-CoV-2 reservoir site and potential intranasal therapy.

27 February 2020 in Neurotoxicity Research
Verified
Journal Article
Closed access
PDF file
CWCaiyan Wen
Caiyan Wen
CHCuiqin Huang
Cuiqin Huang
MYMei Yang
Mei Yang
CFChongzhu Fan
Chongzhu Fan
QLQin Li
Qin Li
DLDaxiang Lu
Daxiang Lu

5 March 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MCMengfei Chen
Mengfei Chen
Andrew PekoszAndrew Pekosz
Andrew Pekosz
JVJason S. Villano
Jason S. Villano
WSWenjuan Shen
Wenjuan Shen
RZRuifeng Zhou
Ruifeng Zhou
ALAndrew P. Lane
Andrew P. Lane
SARS-CoV-2 infection of the upper airway and the subsequent immune response are early, critical factors in COVID-19 pathogenesis. By studying infection of human biopsies in vitro and in a hamster model in vivo, we demonstrated a transition in nasal tropism from olfactory to respiratory epithelium as the virus evolved. Analyzing each variant revealed that SARS-CoV-2 WA1 or Delta infect a proportion of olfactory neurons in addition to the primary target sustentacular cells. The Delta variant possessed broader cellular invasion capacity into the submucosa, while Omicron displayed enhanced nasal respiratory infection and longer retention in the sinonasal epithelium. The olfactory neuronal infection by WA1 and the subsequent olfactory bulb transport via axon were more pronounced in younger hosts. In addition, the observed viral clearance delay and phagocytic dysfunction in aged olfactory mucosa were accompanied by a decline of phagocytosis-related genes. Further, robust basal stem cell activation contributed to neuroepithelial regeneration and restored ACE2 expression postinfection. Together, our study characterized the nasal tropism of SARS-CoV-2 strains, immune clearance, and regeneration after infection. The shifting characteristics of viral infection at the airway portal provide insight into the variability of COVID-19 clinical features, particularly long COVID, and may suggest differing strategies for early local intervention.

9 May 2020 in bioRxiv
Verified
Preprint
Open access
MCMengfei Chen
Mengfei Chen
WSWenjuan Shen
Wenjuan Shen
NRNicholas R. Rowan
Nicholas R. Rowan
HKHeather Kulaga
Heather Kulaga
AHAlexander Hillel
Alexander Hillel
ALAndrew P. Lane
Andrew P. Lane
The site of SARS-CoV-2 entry and replication critically impacts strategies for COVID-19 diagnosis, transmission mitigation, and treatment. We determined the cellular location of the SARS-CoV-2 target receptor protein, ACE2, in the human upper airway, finding striking enrichment (200-700 folds) in the olfactory neuroepithelium relative to nasal respiratory or tracheal epithelial cells. This cellular tropism of SARS-CoV-2 may underlie its high transmissibility and association with olfactory dysfunction, while suggesting a viral reservoir potentially amenable to intranasal therapy.

1 February 2020 in Neurobiology of Aging
Verified
Journal Article
Closed access
ALAn Li
An Li
JZJiayi Zhao
Jiayi Zhao
CFChongzhu Fan
Chongzhu Fan
LZLihong Zhu
Lihong Zhu
CHCuiqin Huang
Cuiqin Huang
DLDaxiang Lu
Daxiang Lu